Showing results (31-40 of 134) with videos related to
Sort By:
Pageof 14
Peptides|March 3, 2007
pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivityWayne D Kohn, Radmila Micanovic, Sharon L Myers, et al.Journal of Diabetes Science and Technology|December 7, 2010
Optimization of the native glucagon sequence for medicinal purposesJoseph R Chabenne, Maria A DiMarchi, Vasily M Gelfanov, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|June 11, 2011
Functional association of the N-terminal residues with the central region in glucagon-related peptidesJames T Patterson, Jonathan W Day, Vasily M Gelfanov, et al.Cell Reports|January 27, 2021
Identification of a second Klotho interaction site in the C terminus of FGF23Archita Agrawal, Pu Ni, Rafiou Agoro, et al.Molecular Metabolism|August 17, 2021
A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptorFa Zhang, Emrah Altindis, C Ronald Kahn, et al.Advanced Drug Delivery Reviews|June 3, 2020
Insights into incretin-based therapies for treatment of diabetic dyslipidemiaKerstin Stemmer, Brian Finan, Richard D DiMarchi, et al.Molecular Metabolism|November 8, 2013
A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transductionJames T Patterson, Pengyun Li, Jonathan W Day, et al.Frontiers in Pharmacology|July 11, 2026
Antagonism of β-klotho signaling by peptide 19 impairs wheel running in male mice and potentiates the cisplatin-induced decrease in wheel runningBrandon M Chelette, Lisa Abe, Chinenye Chidomere, et al.Current Topics in Medicinal Chemistry|June 23, 2007
Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonistsLiang Zeng Yan, Hansen M Hsiung, Mark L Heiman, et al.The Journal of Clinical Investigation|August 6, 2019
CNS-targeting pharmacological interventions for the metabolic syndromeKerstin Stemmer, Timo D Müller, Richard D DiMarchi, et al.Pageof 14